About the Rogel Cancer Center

Radiation oncologist with a patient

Nationally Recognized Cancer Care

Researching ways to prevent cancer, create better treatments and improve quality of life and outcomes for cancer patients and survivors

The Rogel Cancer Center is one of an elite number of programs across the country designated a “comprehensive cancer center” by the National Cancer Institute, a recognition of our excellence in collaborative state-of-the-art cancer research that impacts how cancer is prevented, diagnosed and treated.

Our patient care is consistently rated No. 1 in Michigan and among the best in the nation by U.S. News & World Report. As part of the National Comprehensive Cancer Network, our faculty help set national guidelines for cancer care.

 

The Conquest of Cancer Through Research

The University of Michigan spends the second-highest amount on research of all universities in the United States. It is a broad and deep university with unmatched talent in science, medicine and the humanities. As part of the fabric of the vibrant and diverse research happening across the institution, our cancer center takes advantage of the unique collaborations in our many top-ranked schools and colleges. We can harness innovation by engaging disciplines that are not typically thought to be central to attacking the cancer problem (including faculty in fields like engineering and mathematics), as well as through more traditional collaborations between faculty in medicine, public health, nursing and social work.

Learn more about research at the Rogel Cancer Center.

 

Training the Next Generation of Clinicians and Researchers

In cooperation with the world-renowned U-M Medical School, we are dedicated to educating and training the next generation of oncologists and oncology researchers through fellowship programs, graduate training programs, and postdoctoral programs. The Medical School was the University's first professional school, and since graduating its first class of six students in 1851 — a group which paid a mere $5 for two years of medical education — we have become a leader in preparing the physicians and scientists of the future.

Our students are involved in many research activities, and are given the freedom and resources to pursue those lines of inquiry that are of greatest interest to them. Many will play a crucial role in discoveries that will make an impact worldwide. Our students also play a key role our mission to provide excellence in patient care.

Learn more by visiting our Education and Training page.

News & Stories

microbes inside gut yellow
Health Lab

New oral nanomedicine boosts effectiveness of cancer immunotherapies

University of Michigan researchers developed an oral drug that can increase the ability of T cells to attack tumors. The drug uses the microbial metabolite 3,4-dihydroxybenzoic acid, which is derived from dietary fiber.
Microscope images of prostate cancer cells
Health Lab

New drug combination may help treat advanced prostate cancer

University of Michigan researchers found that combining BET bromodomain and DNMT inhibitors may slow the growth of treatment-resistant prostate cancer by targeting transdifferentiated tumors.
presentation on stage with slideshow up
Health Lab

Medical students develop novel technological solutions for unmet patient needs

University of Michigan medical students showcased AI-driven healthcare innovation projects focused on melanoma support, transplant recovery and primary care access.
cancer cell floating with yellow dots drawn out blue
Health Lab

Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy

The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study by Michigan Medicine.
close up of cells blue purple pink
Health Lab

Researchers create new path to target hard-to-drug prostate cancer protein

University of Michigan researchers have identified a specific pocket within ERG, a driver of prostate cancer, and have developed a small molecule probe, called PBITE-1, that can bind to it.
Health Lab

Path forward for glioblastoma treatment

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment